Shares of Vaccine Makers up on Lancet Retraction

In a statement, Lancet said several elements of the study, performed by Dr. Andrew Wakefield, were “incorrect, contrary to the findings of an earlier investigation.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.